BIOMARIN PHARMACEUTICAL INC Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in BIOMARIN PHARMACEUTICAL INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in BIOMARIN PHARMACEUTICAL INC for June 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Option Exercise | M | 14.39 | 2,150 | 30,939 | 6,450 | |
Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Sell | S | 93.52 | 2,150 | 201,068 | 19,160 | 21.3 K to 19.2 K (-10.09 %) |
Jun 29 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Buy | M | 14.39 | 2,150 | 30,939 | 21,310 | 19.2 K to 21.3 K (+11.22 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.01 | 472 | 46,733 | 51,070 | 51.5 K to 51.1 K (-0.92 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.00 | 9,528 | 943,272 | 51,542 | 61.1 K to 51.5 K (-15.60 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.01 | 472 | 46,733 | 51,070 | 51.5 K to 51.1 K (-0.92 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Sell | S | 99.00 | 9,528 | 943,272 | 51,542 | 61.1 K to 51.5 K (-15.60 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | M | 14.39 | 6,949 | 99,996 | 0 | |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.01 | 328 | 32,475 | 83,276 | 83.6 K to 83.3 K (-0.39 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Option Exercise | M | 14.39 | 6,949 | 99,996 | 0 | |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.00 | 6,621 | 655,479 | 83,604 | 90.2 K to 83.6 K (-7.34 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.01 | 328 | 32,475 | 83,276 | 83.6 K to 83.3 K (-0.39 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Buy | M | 14.39 | 6,949 | 99,996 | 90,225 | 83.3 K to 90.2 K (+8.34 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Sell | S | 99.00 | 6,621 | 655,479 | 83,604 | 90.2 K to 83.6 K (-7.34 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Buy | M | 14.39 | 6,949 | 99,996 | 90,225 | 83.3 K to 90.2 K (+8.34 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Option Exercise | M | 28.23 | 2,491 | 70,321 | 1,718 | |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Option Exercise | M | 28.23 | 2,491 | 70,321 | 1,718 | |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 2,491 | 247,855 | 12,375 | 14.9 K to 12.4 K (-16.76 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 2,491 | 247,855 | 12,375 | 14.9 K to 12.4 K (-16.76 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Buy | M | 28.23 | 2,491 | 70,321 | 14,866 | 12.4 K to 14.9 K (+20.13 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Buy | M | 28.23 | 2,491 | 70,321 | 14,866 | 12.4 K to 14.9 K (+20.13 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 654 | 65,073 | 12,375 | 13 K to 12.4 K (-5.02 %) |
Jun 26 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 99.50 | 654 | 65,073 | 12,375 | 13 K to 12.4 K (-5.02 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Sell | S | 94.50 | 2,021 | 190,985 | 13,029 | 15.1 K to 13 K (-13.43 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 20,681 | 774,710 | 0 | |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 1,875 | 49,669 | 0 | |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 37.46 | 2,669 | 99,981 | 0 | |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 26.49 | 3,775 | 100,000 | 0 | |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Option Exercise | M | 21.51 | 2,000 | 43,020 | 0 | |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 20,681 | 1,861,375 | 155,167 | 175.8 K to 155.2 K (-11.76 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 20,681 | 774,710 | 175,848 | 155.2 K to 175.8 K (+13.33 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 1,875 | 168,750 | 155,167 | 157 K to 155.2 K (-1.19 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 1,875 | 49,669 | 157,042 | 155.2 K to 157 K (+1.21 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 2,669 | 240,210 | 155,167 | 157.8 K to 155.2 K (-1.69 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 37.46 | 2,669 | 99,981 | 157,836 | 155.2 K to 157.8 K (+1.72 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 3,775 | 339,750 | 155,167 | 158.9 K to 155.2 K (-2.38 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 26.49 | 3,775 | 100,000 | 158,942 | 155.2 K to 158.9 K (+2.43 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Sell | S | 90.00 | 2,000 | 180,000 | 155,167 | 157.2 K to 155.2 K (-1.27 %) |
Jun 18 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Buy | M | 21.51 | 2,000 | 43,020 | 157,167 | 155.2 K to 157.2 K (+1.29 %) |
Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | HOMBACH ROBERT J. | Director | Grant | A | 0.00 | 4,300 | 0 | 7,480 | 3.2 K to 7.5 K (+135.22 %) |
Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 106,000 | |
Jun 14 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 285,290 | 284.3 K to 285.3 K (+0.35 %) |
Jun 13 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Sell | S | 90.31 | 1,436 | 129,685 | 50,135 | 51.6 K to 50.1 K (-2.78 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | LAWLIS V BRYAN | Director | Grant | A | 0.00 | 4,300 | 0 | 19,160 | 14.9 K to 19.2 K (+28.94 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | HERON ELAINE J | Director | Grant | A | 0.00 | 4,300 | 0 | 42,685 | 38.4 K to 42.7 K (+11.20 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | GREY MICHAEL G | Director | Grant | A | 0.00 | 4,300 | 0 | 34,110 | 29.8 K to 34.1 K (+14.42 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | Dere Willard H | Director | Grant | A | 0.00 | 4,300 | 0 | 8,990 | 4.7 K to 9 K (+91.68 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | Slamon Dennis | Director | Grant | A | 0.00 | 4,300 | 0 | 14,185 | 9.9 K to 14.2 K (+43.50 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | PYOTT DAVID E I | Director | Grant | A | 0.00 | 4,300 | 0 | 9,210 | 4.9 K to 9.2 K (+87.58 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | MEIER RICHARD A | Director | Grant | A | 0.00 | 4,300 | 0 | 56,610 | 52.3 K to 56.6 K (+8.22 %) |
Jun 07 2018 | BMRN | BIOMARIN PHARMACEU ... | LEWIS ALAN | Director | Grant | A | 0.00 | 4,300 | 0 | 25,360 | 21.1 K to 25.4 K (+20.42 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Payment of Exercise | F | 92.07 | 1,711 | 157,532 | 61,070 | 62.8 K to 61.1 K (-2.73 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | SPIEGELMAN DANIEL K | EVP, Chief Financia ... | Grant | A | 68.78 | 167 | 11,487 | 62,781 | 62.6 K to 62.8 K (+0.27 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | Mueller Brian | SVP, Corporate Cont ... | Payment of Exercise | F | 92.07 | 346 | 31,856 | 15,050 | 15.4 K to 15.1 K (-2.25 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | Ajer Jeffrey Robert | EVP, Chief Commerci ... | Payment of Exercise | F | 92.07 | 1,414 | 130,187 | 51,571 | 53 K to 51.6 K (-2.67 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Payment of Exercise | F | 92.07 | 1,562 | 143,813 | 83,276 | 84.8 K to 83.3 K (-1.84 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BAFFI ROBERT | EVP, Technical Oper ... | Grant | A | 68.78 | 309 | 21,254 | 84,838 | 84.5 K to 84.8 K (+0.37 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 92.07 | 6,310 | 580,962 | 284,290 | 290.6 K to 284.3 K (-2.17 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Payment of Exercise | F | 92.07 | 1,934 | 178,063 | 155,167 | 157.1 K to 155.2 K (-1.23 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | FUCHS HENRY J | President, Worldwid ... | Grant | A | 68.78 | 309 | 21,254 | 157,101 | 156.8 K to 157.1 K (+0.20 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Payment of Exercise | F | 92.07 | 1,414 | 130,187 | 86,950 | 88.4 K to 87 K (-1.60 %) |
Jun 06 2018 | BMRN | BIOMARIN PHARMACEU ... | Davis George Eric | EVP, General Counse ... | Grant | A | 68.78 | 309 | 21,254 | 88,364 | 88.1 K to 88.4 K (+0.35 %) |